Skip to content

L-PRF vs Connective Tissue With Customized Healing Abutment in Immediate Implant Placement

Evaluation of Soft and Hard Tissue Augmentation by Connective Tissue Graft or Leukocyte-Platelet Rich Fibrin in Immediate Implant Placement With Customized Healing Abutment: A Randomized Controlled Clinical Trial.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07102758
Enrollment
16
Registered
2025-08-05
Start date
2025-08-05
Completion date
2027-08-20
Last updated
2025-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Loss in Jaw, Recession, Gingival

Keywords

L-prf, connective tissue, customized healing abutment, implant

Brief summary

comparison between L-prf and connective tissue with dental implant

Detailed description

comparison between L-PRF and Connective tissue with customized healing abutment regaring soft and hard tissue outcomes with immediate dental implants.

Interventions

PROCEDUREL-PRF with dental implant and customized healing abutment

L-PRF with dental implant and customized healing abutment

PROCEDUREConnective tissue with dental implant and customized healing abutment

Connective tissue with dental implant and customized healing abutment

Sponsors

Kafrelsheikh University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Intact labial/buccal bone plate * The presence of non-restorable single-rooted maxillary centrals, canines or premolars. * Sufficient bone volume. * Good oral hygiene. * Nonsmokers. * Sufficient bone width (≥ 1 mm) in the buccal plate of the remaining bone to place an implant confirmed by cone beam computer tomography (CBCT).

Exclusion criteria

* Insufficient bone volume. * Active infection. * Patients on chemotherapy or radiotherapy. * Patients who have systemic disorders {uncontrolled diabetes mellitus, autoimmune disease, …etc}, * Pregnant patients, * Patients with bone diseases * Presence of periapical pathology.

Design outcomes

Primary

MeasureTime frameDescription
Patient-reported pain experiencefirst 7 days after surgeryPain experience after surgery is daily measured by the patients using a visual analogue scale (VAS) in the first postoperative 7 days, with Day 0 being the day of the surgery. Before going to sleep, patients will be asked to mark the VAS that best represented the average pain they had experienced during the day.
Pink aesthetic scorebefore surgery, 3 months and 6 months after surgeryParameters are : 0,1 and 2. Mesial papilla : 0 ( Missing ) , 1 ( Incomplete ) and 2 ( Complete ). Distal Papilla : 0 ( Missing ) , 1 ( Incomplete ) and 2 ( Complete ). Tissue contour : 0 ( Unnatural) , 1 ( virtually natural ) and 2 ( natural). Gingival level : 0 ( \>2mm) , 1 ( 1-2mm ) and 2 ( 1 mm). Alveolar process : 0 ( clearly resorbed ) , 1 ( slightly resorbed ) and 2 ( no difference). Coloring : 0 ( clear difference ) , 1 ( slight difference ) and 2 ( no difference). Texture : 0 ( clear difference ) , 1 ( slight difference ) and 2 ( no difference).
crestal bone losspreoperative and 6 months post operativedistance from implant shoulder to marginal bone

Secondary

MeasureTime frameDescription
Gingival thicknesspre opearative, 3 and 6 months post operative1 mm apical to gingival margin in mid buccal
probing pocket depthpreoperative , 3 and 6 months post operativemid buccal , mesio buccal , disto buccal and mid palatal
keratinized tissue widthpreoperative , 3 and 6 months post operativein mid buccal, from gingival margin to mucogingival junction

Countries

Egypt

Contacts

Primary ContactAhmed Atef Salem, General doctor
dent.ahmedatef@gmail.com0201007737797

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026